Mural Oncology plc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mural Oncology plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2022 to Q3 2024.
  • Mural Oncology plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$31.8M, a 38.1% increase year-over-year.
  • Mural Oncology plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$154M, a 21.7% increase year-over-year.
  • Mural Oncology plc annual Net Income (Loss) Attributable to Parent for 2023 was -$207M, a 9.29% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$154M -$31.8M +$19.5M +38.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$173M -$31.6M +$18.2M +36.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$192M -$30.9M +$15.9M +34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$207M -$59.5M -$11M -22.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 -$196M -$51.3M -$635K -1.25% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$196M -$49.8M -$6.47M -14.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$189M -$46.8M +$418K +0.88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$190M -$48.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$50.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-14
Q2 2022 -$43.3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-12-14
Q1 2022 -$47.3M Jan 1, 2022 Mar 31, 2022 10-Q 2023-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.